Holen Sie sich die Stockscreener-App
32.24
0.25%
0.08
Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten
Lupin Concedes To Harmony On Generic Wakix With 2030 Launch Agreement - insights.citeline.com
Harmony Biosciences Presents Promising Preclinical Data for Novel Narcolepsy Treatment - MyChesCo
Rhumbline Advisers Increases Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
(HRMY) Investment Analysis - news.stocktradersdaily.com
Equities Analysts Set Expectations for HRMY FY2026 Earnings - Defense World
Harmony Biosciences Presents Preclinical Data Demonstrating Sign - GuruFocus
Harmony Biosciences to begin human trials of narcolepsy drug in 2025 By Investing.com - Investing.com South Africa
Harmony Biosciences to begin human trials of narcolepsy drug in 2025 - Investing.com Canada
HRMY: Harmony Biosciences Shows Promising Preclinical Data for BP1.15205 | HRMY Stock News - GuruFocus
Harmony Biosciences (HRMY) Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 - StreetInsider
Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025 - Business Wire
Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory - MSN
Harmony Biosciences Reaches Settlement with Lupin Over WAKIX® Patent Litigation - MSN
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by California State Teachers Retirement System - Defense World
Transcript : Harmony Biosciences Holdings, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 03 - MarketScreener
Harmony Biosciences settles patent litigation with Lupin By Investing.com - Investing.com South Africa
Harmony Biosciences, Lupin reach agreement on Wakix generic launch - MSN
Harmony Biosciences: If It Ain't Broke (NASDAQ:HRMY) - Seeking Alpha
Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation - BioSpace
Harmony Biosciences (HRMY) Settles Patent Dispute with Lupin | HRMY Stock News - GuruFocus
Harmony Biosciences settles patent litigation with Lupin - Investing.com Australia
Harmony Biosciences Strengthens Patent Position With Favorable Settlement In ANDA Litigation - MarketScreener
Harmony Biosciences Strengthens Patent Position With Favorable S - GuruFocus
Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation | HRMY Stock News - GuruFocus
Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference | HRMY Stock News - GuruFocus
Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference - Yahoo Finance
Top 5 US Stocks To Buy In June 2025 - Investing.com
Harmony Biosciences (NASDAQ:HRMY) Now Covered by Analysts at Oppenheimer - Defense World
Where Harmony Biosciences Hldgs Stands With Analysts - Benzinga
Oppenheimer Sets $61 Price Target for Harmony Biosciences (HRMY) | HRMY Stock News - GuruFocus
(HRMY) On The My Stocks Page - news.stocktradersdaily.com
Oppenheimer assumes Outperform rating on Harmony Biosciences stock By Investing.com - Investing.com Nigeria
Oppenheimer assumes Outperform rating on Harmony Biosciences stock - Investing.com
Harmony Biosciences (HRMY) Receives Outperform Rating from Oppen - GuruFocus
Oppenheimer Assumes Harmony Biosciences Holdings Inc. (HRMY) at Outperform - StreetInsider
Oppenheimer Sets $61 Price Target for Harmony Biosciences (HRMY) - GuruFocus
Nuveen Asset Management LLC Buys 8,193 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Bank of America Corp DE Decreases Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Ameriprise Financial Inc. Purchases 18,730 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of “Buy” by Analysts - Defense World
When (HRMY) Moves Investors should Listen - news.stocktradersdaily.com
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Deutsche Bank AG - Defense World
A Piece Of The Puzzle Missing From Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) 26% Share Price Climb - simplywall.st
BNP Paribas Financial Markets Invests $2.03 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences (NASDAQ:HRMY) Price Target Raised to $48.00 - Defense World
The Manufacturers Life Insurance Company Acquires 2,144 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Position Increased by Northern Trust Corp - Defense World
Comerica Bank Acquires 2,919 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences (NASDAQ:HRMY) Upgraded at Cantor Fitzgerald - Defense World
Harmony Biosciences (HRMY): Mizuho Raises Price Target to $48 | - GuruFocus
Harmony Biosciences (HRMY): Mizuho Raises Price Target to $48 | HRMY Stock News - GuruFocus
Mizuho raises Harmony Biosciences stock target to $48 - Investing.com
Harmony Biosciences (HRMY) Sees Price Target Increase Following Positive Q1 Results | HRMY Stock News - GuruFocus
Mizuho raises Harmony Biosciences stock target to $48 By Investing.com - Investing.com India
1.08%
2.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):